COMPARISON OF DENTIN HYPERSENSITIVITY MANAGEMENT
By Dentin Bonding Agent and Thinly Applied Glass Ionomer Cement: A Clinical Trial
BACKGROUND: Dentin hypersensitivity is a widespread issue in dentistry, often referred to as the “common cold” of dental problems. This study aimed to compare the effectiveness of glass ionomer cement and dentin bonding agent in treating this condition at Peshawar Dental College.
METHODS: This study involved 60 patients aged 18-70, treated from February to August 2022. Patients were divided into two groups: Group A received glass ionomer cement, while Group B received a dentin bonding agent. Sensitivity was measured before treatment and again immediately after, as well as one week and six weeks later, using a visual analogue scale.
RESULTS: Both groups showed a decrease in pain from severe to mild or no pain immediately after treatment. At the one-week follow-up, most patients reported mild or no pain, and after six weeks, most still experienced only mild pain. There was no significant difference in pain levels between the two groups at these follow-ups.
CONCLUSIONS: While there was a notable difference in pain scores immediately after treatment, by one and six weeks later, both treatments resulted in similar outcomes with most patients reporting mild pain.
Clinical Trials: These are essential for developing safe and effective treatments. It’s vital to integrate their findings into everyday medical practice. Our AI-driven platform, DocSym, consolidates clinical standards and research into a user-friendly resource for healthcare providers.
Streamlining Healthcare: In today’s medical environment, efficient operations are key. Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, simplifying patient care and expanding digital services.
Enhancing Patient Outcomes: By utilizing AI, clinics can improve workflows, enhance patient outcomes, and reduce paperwork. Discover how we can assist you at aidevmd.com.
